GeneBio Systems
DRG1 Polyclonal Antibody
DRG1 Polyclonal Antibody
SKU:E-AB-14961
Couldn't load pickup availability
Size: 200μL
Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date: 12 months
Category ID_II: Primary Antibodies
Category ID_III: Polyclonal Antibodies
Abbreviation: DRG1
Target Synonym: Developmentally regulated GTP binding protein 1;Developmentally-regulated GTP-binding protein 1;DKFZp434N1827;DRG 1;DRG-1;DRG1;DRG1;NEDD 3;NEDD-3;NEDD3;Neural precursor cell expressed developmentally down regulated protein 3;Neural precursor cell expressed developmentally down-regulated protein 3
Research Areas: Cancer;Cell Biology;Signal Transduction
Conjugation: Unconjugated
Host: Rabbit
Species reactivity: Human;Mouse
Application: WB
Isotype: IgG
Clonality: Polyclonal
Clone NO.:
UNIProt ID: Q9Y295
Accession:
Background: DRG1 (developmentally regulated GTP binding protein 1), also known as NEDD3 (neural precursor cell expressed developmentally down-regulated protein 3), is a 367 amino acid protein that localizes to the cytoplasm and belongs to the GTP1/OBG family. Expressed at high levels in heart, kidney and skeletal muscle and at lower levels in brain, liver, placenta, lung, colon and spleen, DRG1 binds to TAL1 and TAL2 and is thought to play a role in cell proliferation and differentiation, as well as in apoptosis, suggesting a role in tumor formation and metastasis. DRG1 is subject to polyubiquitination and sumoylation, the former of which induces proteolytic degradation. The gene encoding DRG1 maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, Neurofibromatosis type 2, autism and schizophrenia.
Concentration: 0.6 mg/mL
Immunogen: Recombinant protein of human DRG1
Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification method: Affinity purification
Dilution: WB 1:500-1:2000
Calculated MW: 41kDa
ObservedMW:
